(NASDAQ: REGN) and Sanofi today presented results from the DISCOVER Phase 4, single-arm, open-label trial assessing Dupixent ® (dupilumab) in adults and adolescents with moderate-to-severe atopic ...

Ro Weight Loss, a digital health service from Roman Health Ventures Inc., has updated its official website to provide new ...